COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
15/10/2026
Transaction Expected to Increase Stockholders’ Equity; Opens Potential Collaboration Opportunities From New Strategic Alliances LITTLETON, Colo., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or [...]
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
15/10/2026
Direct-from-Source Access Deepens Longitudinal Clinical Records, Strengthening OneMedNet's Position as a Preferred Source of Regulatory-Grade, AI-Ready Real-World Data MINNEAPOLIS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- [...]
Sienna Announces October Dividend
15/10/2026
MARKHAM, Ontario, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026
15/10/2026
Management to outline ‘PolyPid 2030’, the Company’s long-term vision and pipeline strategy Event to feature Warren S. Joseph, DPM, FIDSA, a nationally recognized specialist in lower extremity infectious diseases Petach [...]
CytoDyn to Host Investor Webcast
15/10/2026
VANCOUVER, Wash., Oct. 15, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls
15/10/2026
Listeria dropped from tens of millions of bacteria to undetectable or near-undetectable levels, as TOMI partners with an industry expert to expand in food safety FREDERICK, Md., Oct. 15, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
15/10/2026
In advance of November 10, 2026, GDUFA goal date, all requested changes were classified as “MINOR.” NRx was requested to prepare and submit labels with the proprietary name currently under review by FDA. NRx is [...]
Recursion Announces $200 Million Oversubscribed Follow-On Offering, Clinical Data Updates, and Partnership Milestone
15/10/2026
Leading Healthcare Investors, includ ing Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest $200 million in [...]
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
15/10/2026
SEATTLE, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates
15/10/2026
New Taipei City, Taiwan, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization [...]
Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis
15/10/2026
Eupraxia reached its target enrollment of 120 patients in the Phase 2b placebo-controlled blinded portion of the RESOLVE trial The Company has a statistical team who are doing periodic reviews of the unblinded data to [...]
ORYZON further strengthens vafidemstat’s patent portfolio with new decisions to grant
15/10/2026
New patent allowances in South Korea, Mexico, New Zealand and the Philippines Further expand IP protection across BPD, ASD, aggression and social withdrawal MADRID and CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE [...]
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy
15/10/2026
LB2501 is an off-the-shelf in vivo CAR-T therapy designed to generate dual-targeting CD19/CD20 CAR-T cells directly within the patient after a single infusion, making it the first known dual-targeting in vivo CAR-T [...]
Callio Therapeutics Wins Best New ADC Drug Developer at the 13th World ADC Awards, Presents Across Five Sessions at World ADC San Diego
15/10/2026
Callio leaders delivered three presentations and two panel discussions on dual-payload ADC resistance, manufacturability, linker design, and the path to next-generation ADCs SAN DIEGO, SEATTLE and SINGAPORE, Oct. 15, [...]
Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
15/10/2026
Internally-derived candidate targets wild-type androgen receptor and clinically relevant variants implicated in resistance to conventional prostate cancer therapies MILLBRAE, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- [...]
Nema Health Expands Access to Specialized PTSD Treatment Through Evernorth Behavioral Health Network
15/10/2026
New in-network agreement makes evidence-based trauma treatment more accessible to eligible Cigna Healthcare and Evernorth members NEW HAVEN, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Nema Health, a virtual specialty care [...]
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
15/10/2026
Initial Stage 1 data evaluating ven s obafusp alfa in IgAN expected by year-end 2026 Announces e xpansion cohort in patients with FSGS , with first patients anticipated to be dosed in first quarter 2027 REDWOOD CITY, [...]
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
15/10/2026
FDA-cleared BVA ™ technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. Key Highlights: Commercial Acceleration: Daxor showcasing its [...]
IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference
15/10/2026
NEW HAVEN, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapeutics for serious [...]

Pages